methods for the measurement and prediction of response to hepatotoxicants and carcinogens through the detection of metabolites in a mammal are provided . the metabolites can be used as biomarkers , including efficacy biomarkers , surrogate biomarkers , and toxicity biomarkers . the methods find use for early prediction of toxicity , target identification / validation , and monitoring of drug efficacy .